cavity frequency pulling

(Return tabled) Question No. 334 Hon. Irwin Cotler: With regard to bijuralism and harmonization: (a) what measures are in place to ensure legislative bijuralism across all departments; (b) since the adoption of the “Policy on Legislative Bijuralism”, how has the Department of Justice (i) ensured that all legal counsel in the Department are made aware of the requirements of legislative bijuralism in order for them to be able to take it into account when advising client departments on legislative reforms, (ii) enhanced the capacity of the Legislative Services Branch to draft bijural legislative texts, (iii) undertook, in drafting both versions of every bill and proposed regulation that touches on provincial or territorial private law, to tak ...[+++]e care to reflect the terminology, concepts, notions and institutions of both of Canada’s private law systems; (c) since the adoption of the “Policy for Applying the Civil Code of Quebec to Federal Government Activities”, what measures are in place to ensure (i) changes to Quebec’s Civil Code are known and monitored by the government, (ii) assessment of federal legislation relative to changes to Quebec’s Civil Code, (iii) federal legislation is introduced to reflect, where necessary, changes to the Civil Code of Quebec; (d) with respect to the “Index of Bijuralism and Harmonization Caselaw” found online and indicating its most recent update was June 12, 2012, (i) how often is this page updated, (ii) given that some cases thereupon are from 2013, when was this page last updated, (iii) whose responsibility is it to update this page, (iv) what cases are currently being monitored for potential addition to this page; (e) with respect to cases involving bijuralism and harmonization, (i) in what ways are these made known to the Department, (ii) whose responsibility it is to monitor these cases, (iii), what role does the Federal government play in these cases if a party, (iv) what role does the government play if not a party, (v) who m ...

Manufacturers of devices classified in class IIb and III shall report to the electronic system referred to in Article 62 any statistically significant increase in the frequency or severity of incidents that are not serious incidents or of expected undesirable side-effects that have a significant impact on the risk-benefit analysis referred to in Sections 1 and 5 of Annex I and which have led or may lead to unacceptable risks to the health or safety of patients, users or other persons when weighted against the intended benefits.

A. whereas hormone-related disorders and illnesses in humans have increased over the last 20 years, including impaired sperm quality, early onset of puberty, increased incidence of deformed sexual organs, increased incidence of certain forms of cancer, and metabolic diseases; whereas certain neurological disorders and neurodegenerative diseases, impacts on neurodevelopmental functions, the immune system or epigenetics, might be linked to exposure to chemical substances with endocrine-disrupting properties; whereas further research is needed to obtain a better understanding of the causes of such diseases;

A. whereas hormone-related disorders and illnesses in humans have increased over the last 20 years, including impaired sperm quality, early onset of puberty, increased incidence of deformed sexual organs, increased incidence of certain forms of cancer , and metabolic diseases; whereas certain neurological disorders and neurodegenerative diseases, impacts on neurodevelopmental functions, the immune system or epigenetics, might be linked to exposure to chemical substances with endocrine-disrupting properties; whereas further research is needed to obtain a better understanding of the causes of such diseases;